Golden
Hopen Life Science Ventures

Hopen Life Science Ventures

Hopen Life Science Ventures is a Grand Rapids, Michigan based venture capital firm focused on early-to-mid-stage investments in life sciences companies.

Hopen Life Science Ventures is a Grand Rapids, Michigan and Westlake, Ohio based venture capital firm. They invest in early to mid-stage life sciences companies, especially in medical devices, diagnostics, therapeutics, healthcare information technology, and drug discovery enabling technology sectors. Hopen Life Science Ventures prefers to invest in the Midwest of the United States, feeling this is a market under-served by venture capital firms.



Hopen Life Science Ventures offers their portfolio companies funding, developmental and managerial experience and support as well as an industry network.



Investment

Hopen Life Science Ventures has made investments in Cirius Therapeutics, Delphinus Medical Technologies, NeoChord, Sierra Oncology, Tolera Therapeutics, Bjond and Prevacept Infection Control.



They have exited their investment in Sierra Oncology.

Timeline

Funded Companies

1 Result
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

A biotechnology company developing therapeutics for the treatment of dieseases

People

Name
Role
LinkedIn

Dan Hartmand, MD, FCCP

Scientific and Medical Advisory Board



Douglas Morton, PhD

Scientific and Medical Advisory Board Chair



Jerry Callahan, PhD

Venture Partner



Mark Olesnavage

Managing Director



Michael Fulton, MD

Managing Director



Michael Jandernoa

Managing General Partner



Nathan Fredrickson

Associate



Thomas Buschert, CPA

Chief Financial Officer



W. Gary Tarpley, PhD

Scientific and Medical Advisory Board



William Baer, MD, PharmD

Scientific and Medical Advisory Board



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References